IFNG and colitis: In the present study, 9 μM DCL inhibited LPS/IFNγ-induced activation of MAPKs in RAW264.7 cells, suggesting that the DCL-induced inhibition of MAPK activation may contribute to its anti-inflammatory and anti-colitis effects.